Tatem's verdict: DSIP is a weak chronobiologic nudge like melatonin, not a sedative
Dr. Tatem's overall stance is skeptical. He says DSIP should not be thought of like Ambien; it is not a sedative and nothing in the human record shows it dropping people in 20 minutes. He characterizes it as a slow nudge to the sleep system and body clock, a chronobiologic much like melatonin but not a knockout. Unlike CJC/Cortexin's 30-year Russian track record, DSIP lacks approval for the sleep indication people want. His verdict: adults with wrecked sleep should not reach for gray-market DSIP first but focus on sleep basics (consistent schedule, sunlight, no night screens, dark cold room, less alcohol, rule out apnea), and he says we honestly just need more data.